Cargando…

Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer’s Disease

BACKGROUND: Neurofibrillary tangle (NFT) accumulation in the entorhinal cortex (EC) precedes the transformation from cognitive controls to mild cognitive impairment and Alzheimer’s disease (AD). While tauopathy has been described in the EC before, the order and degree to which the individual subfiel...

Descripción completa

Detalles Bibliográficos
Autores principales: Llamas-Rodríguez, Josué, Oltmer, Jan, Greve, Douglas N., Williams, Emily, Slepneva, Natalya, Wang, Ruopeng, Champion, Samantha, Lang-Orsini, Melanie, Fischl, Bruce, Frosch, Matthew P., van der Kouwe, André J.W., Augustinack, Jean C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198759/
https://www.ncbi.nlm.nih.gov/pubmed/35491780
http://dx.doi.org/10.3233/JAD-215567
_version_ 1784727698178834432
author Llamas-Rodríguez, Josué
Oltmer, Jan
Greve, Douglas N.
Williams, Emily
Slepneva, Natalya
Wang, Ruopeng
Champion, Samantha
Lang-Orsini, Melanie
Fischl, Bruce
Frosch, Matthew P.
van der Kouwe, André J.W.
Augustinack, Jean C.
author_facet Llamas-Rodríguez, Josué
Oltmer, Jan
Greve, Douglas N.
Williams, Emily
Slepneva, Natalya
Wang, Ruopeng
Champion, Samantha
Lang-Orsini, Melanie
Fischl, Bruce
Frosch, Matthew P.
van der Kouwe, André J.W.
Augustinack, Jean C.
author_sort Llamas-Rodríguez, Josué
collection PubMed
description BACKGROUND: Neurofibrillary tangle (NFT) accumulation in the entorhinal cortex (EC) precedes the transformation from cognitive controls to mild cognitive impairment and Alzheimer’s disease (AD). While tauopathy has been described in the EC before, the order and degree to which the individual subfields within the EC are engulfed by NFTs in aging and the preclinical AD stage is unknown. OBJECTIVE: We aimed to investigate substructures within the EC to map the populations of cortical neurons most vulnerable to tau pathology in aging and the preclinical AD stage. METHODS: We characterized phosphorylated tau (CP13) in 10 cases at eight well-defined anterior-posterior levels and assessed NFT density within the eight entorhinal subfields (described by Insausti and colleagues) at the preclinical stages of AD. We validated with immunohistochemistry and labeled the NFT density ratings on ex vivo MRIs. We measured subfield cortical thickness and reconstructed the labels as three-dimensional isosurfaces, resulting in anatomically comprehensive, histopathologically validated tau “heat maps.” RESULTS: We found the lateral EC subfields ELc, ECL, and ECs (lateral portion) to have the highest tau density in semi-quantitative scores and quantitative measurements. We observed significant stepwise higher tau from anterior to posterior levels (p < 0.001). We report an age-dependent anatomically-specific vulnerability, with all cases showing posterior tau pathology, yet older individuals displaying an additional anterior tau burden. Finally, cortical thickness of each subfield negatively correlated with respective tau scores (p < 0.05). CONCLUSION: Our findings indicate that posterior-lateral subfields within the EC are the most vulnerable to early NFTs and atrophy in aging and preclinical AD.
format Online
Article
Text
id pubmed-9198759
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-91987592022-06-16 Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer’s Disease Llamas-Rodríguez, Josué Oltmer, Jan Greve, Douglas N. Williams, Emily Slepneva, Natalya Wang, Ruopeng Champion, Samantha Lang-Orsini, Melanie Fischl, Bruce Frosch, Matthew P. van der Kouwe, André J.W. Augustinack, Jean C. J Alzheimers Dis Research Article BACKGROUND: Neurofibrillary tangle (NFT) accumulation in the entorhinal cortex (EC) precedes the transformation from cognitive controls to mild cognitive impairment and Alzheimer’s disease (AD). While tauopathy has been described in the EC before, the order and degree to which the individual subfields within the EC are engulfed by NFTs in aging and the preclinical AD stage is unknown. OBJECTIVE: We aimed to investigate substructures within the EC to map the populations of cortical neurons most vulnerable to tau pathology in aging and the preclinical AD stage. METHODS: We characterized phosphorylated tau (CP13) in 10 cases at eight well-defined anterior-posterior levels and assessed NFT density within the eight entorhinal subfields (described by Insausti and colleagues) at the preclinical stages of AD. We validated with immunohistochemistry and labeled the NFT density ratings on ex vivo MRIs. We measured subfield cortical thickness and reconstructed the labels as three-dimensional isosurfaces, resulting in anatomically comprehensive, histopathologically validated tau “heat maps.” RESULTS: We found the lateral EC subfields ELc, ECL, and ECs (lateral portion) to have the highest tau density in semi-quantitative scores and quantitative measurements. We observed significant stepwise higher tau from anterior to posterior levels (p < 0.001). We report an age-dependent anatomically-specific vulnerability, with all cases showing posterior tau pathology, yet older individuals displaying an additional anterior tau burden. Finally, cortical thickness of each subfield negatively correlated with respective tau scores (p < 0.05). CONCLUSION: Our findings indicate that posterior-lateral subfields within the EC are the most vulnerable to early NFTs and atrophy in aging and preclinical AD. IOS Press 2022-05-31 /pmc/articles/PMC9198759/ /pubmed/35491780 http://dx.doi.org/10.3233/JAD-215567 Text en © 2022 – IOS Press. All rights reserved https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) License (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Llamas-Rodríguez, Josué
Oltmer, Jan
Greve, Douglas N.
Williams, Emily
Slepneva, Natalya
Wang, Ruopeng
Champion, Samantha
Lang-Orsini, Melanie
Fischl, Bruce
Frosch, Matthew P.
van der Kouwe, André J.W.
Augustinack, Jean C.
Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer’s Disease
title Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer’s Disease
title_full Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer’s Disease
title_fullStr Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer’s Disease
title_full_unstemmed Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer’s Disease
title_short Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer’s Disease
title_sort entorhinal subfield vulnerability to neurofibrillary tangles in aging and the preclinical stage of alzheimer’s disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198759/
https://www.ncbi.nlm.nih.gov/pubmed/35491780
http://dx.doi.org/10.3233/JAD-215567
work_keys_str_mv AT llamasrodriguezjosue entorhinalsubfieldvulnerabilitytoneurofibrillarytanglesinagingandthepreclinicalstageofalzheimersdisease
AT oltmerjan entorhinalsubfieldvulnerabilitytoneurofibrillarytanglesinagingandthepreclinicalstageofalzheimersdisease
AT grevedouglasn entorhinalsubfieldvulnerabilitytoneurofibrillarytanglesinagingandthepreclinicalstageofalzheimersdisease
AT williamsemily entorhinalsubfieldvulnerabilitytoneurofibrillarytanglesinagingandthepreclinicalstageofalzheimersdisease
AT slepnevanatalya entorhinalsubfieldvulnerabilitytoneurofibrillarytanglesinagingandthepreclinicalstageofalzheimersdisease
AT wangruopeng entorhinalsubfieldvulnerabilitytoneurofibrillarytanglesinagingandthepreclinicalstageofalzheimersdisease
AT championsamantha entorhinalsubfieldvulnerabilitytoneurofibrillarytanglesinagingandthepreclinicalstageofalzheimersdisease
AT langorsinimelanie entorhinalsubfieldvulnerabilitytoneurofibrillarytanglesinagingandthepreclinicalstageofalzheimersdisease
AT fischlbruce entorhinalsubfieldvulnerabilitytoneurofibrillarytanglesinagingandthepreclinicalstageofalzheimersdisease
AT froschmatthewp entorhinalsubfieldvulnerabilitytoneurofibrillarytanglesinagingandthepreclinicalstageofalzheimersdisease
AT vanderkouweandrejw entorhinalsubfieldvulnerabilitytoneurofibrillarytanglesinagingandthepreclinicalstageofalzheimersdisease
AT augustinackjeanc entorhinalsubfieldvulnerabilitytoneurofibrillarytanglesinagingandthepreclinicalstageofalzheimersdisease